(Q48552259)

English

Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata.

scientific article published in November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

Dopamine D1- and D2-dependent catalepsy in the rat requires functional NMDA receptors in the corpus striatum, nucleus accumbens and substantia nigra pars reticulata. (English)

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

nucleus accumbens

1 reference

based on heuristic

inferred from title

substantia nigra

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ozer H

1

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

Ekinci AC

2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

Starr MS

3

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

777

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

1-2

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

51-59

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

Feline subthalamic nucleus neurons contain glutamate-like but not GABA-like or glycine-like immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The substantia nigra as a site of synaptic integration of functionally diverse information arising from the ventral pallidum and the globus pallidus in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Neuroleptic-induced catalepsy as a model of Parkinson's disease. II. Effect of glutamate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Intracerebral SCH 23390 and catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

N-Methyl-d-Aspartate Antagonists in the Treatment of Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The role of the corpus striatum in neuroleptic- and narcotic-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The role of excitatory amino acids in experimental models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Alternatively spliced isoforms of the NMDAR1 glutamate receptor subunit: differential expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Intranigral but not intrastriatal microinjection of the NMDA antagonist MK-801 induces contralateral circling in the 6-OHDA rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Involvement of the substantia innominata/ventral pallidum complex in transmitting forelimb muscular rigidity evoked from the nucleus accumbens in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Distinct sites of dopaminergic and glutamatergic regulation of haloperidol-induced catalepsy within the rat caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900706-3

7 January 2021

Identifiers

10.1016/S0006-8993(97)00706-3

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

release_i2fxrjz6ufag7coerxrrykwcdi

1 reference

https://api.fatcat.wiki/v0/release/i2fxrjz6ufag7coerxrrykwcdi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 February 2018

http://europepmc.org/abstract/MED/9449412

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48552259&oldid=1837150847"